Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line—IPO43
Funding Information: We acknowledge to Unidade Investigação Patobiologia Molecular (UIPM) facilities and to Pathology Department of Instituto Português de Oncologia Francisco Gentil de Lisboa (IPOLFG). We acknowledge funding from the iNOVA4Health—UIDB/04462/2020 and UIDP/04462/2020, a program financ...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2022
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10362/139239 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/139239 |
Resumo: | Funding Information: We acknowledge to Unidade Investigação Patobiologia Molecular (UIPM) facilities and to Pathology Department of Instituto Português de Oncologia Francisco Gentil de Lisboa (IPOLFG). We acknowledge funding from the iNOVA4Health—UIDB/04462/2020 and UIDP/04462/2020, a program financially supported by Fundação para a Ciência e Tecnologia / Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES), through national funds”. Funding Information: The authors declare that the article was partially funded by iNOVA4Health—UIDB/04462/2020 and iNOVA4Health—UIDP/04462/2020. |
---|